{"meta":{"query_hash":"c68c762d5bf5","filters":{"venue":"Journal of Managed Care Pharmacy"},"cohort_total":34,"direct_labels_cover":0,"predictions_cover":34,"exported":34,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/c68c762d5bf5","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Managed+Care+Pharmacy"},"results":[{"id":"W2096831111","doi":"10.18553/jmcp.2005.11.3.211","title":"Effect of Prescriber Education on the Use of Medications Contraindicated in Older Adults in a Managed Medicare Population","year":2005,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Medicare Part D; Medical prescription; Managed care; Population; Prescription drug; Medicare Advantage; Medication therapy management; Pharmacist; Incidence (geometry); Quarter (Canadian coin); Family medicine; Emergency medicine; Health care; Nursing","score_opus":0.06944851455571585,"score_gpt":0.41027713473778743,"score_spread":0.3408286201820716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096831111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884317,0.0009817138,0.000016086044,0.008795394,0.0001954258,0.0010262245,0.0000074251843,0.000005860312,0.00054015],"genre_scores_gemma":[0.99815226,0.00037077628,0.00010476435,0.0011661289,0.00010549723,0.000019231531,0.000026582908,0.000013626486,0.00004112475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761623,0.0006824013,0.0008278962,0.00012199307,0.00059929915,0.00015218215],"domain_scores_gemma":[0.997373,0.0013926927,0.00073861075,0.00018842057,0.00019095416,0.00011632307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010970954,0.00013119477,0.0003948454,0.0004779275,0.000027684022,0.000008419272,0.00016633463,0.000048690443,0.00018219958],"category_scores_gemma":[0.0010780023,0.00008320718,0.00013595568,0.00039382512,0.000053923184,0.00031866122,0.000024104154,0.0006404339,0.000002458687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008053802,0.001878411,0.5029475,0.0018801343,0.00040347443,0.00006194046,0.007945594,0.00072844967,0.0011491133,0.00020930631,0.0031587968,0.4715835],"study_design_scores_gemma":[0.028868817,0.0010006859,0.9249876,0.0048789736,0.0015559453,0.00006395444,0.0025122692,0.00805178,0.010615311,0.00002941257,0.017169653,0.00026557277],"about_ca_topic_score_codex":0.00021846376,"about_ca_topic_score_gemma":0.000059084407,"teacher_disagreement_score":0.47131792,"about_ca_system_score_codex":0.00014813746,"about_ca_system_score_gemma":0.000097564545,"threshold_uncertainty_score":0.33930904},"labels":[],"label_agreement":null},{"id":"W2101212412","doi":"10.18553/jmcp.2009.15.6.476","title":"Retrospective Observational Assessment of Statin Adherence Among Subjects Patronizing Different Types of Community Pharmacies in Canada","year":2009,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"Fondation pour la Recherche Médicale","keywords":"Medicine; Medical prescription; Pharmacy; Statin; Family medicine; Observational study; Retrospective cohort study; Prescription drug; Emergency medicine; Internal medicine; Pharmacology","score_opus":0.08833362095337416,"score_gpt":0.37750319978693053,"score_spread":0.2891695788335564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101212412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972695,0.000513468,0.00019132528,0.0004523064,0.00013178591,0.00018410834,0.0000126548375,0.0000034495945,0.0012414083],"genre_scores_gemma":[0.99888194,0.00027300653,0.00039732113,0.00034301396,0.00004005866,0.0000033122778,0.000010547149,0.000005439847,0.00004537111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826944,0.00021950234,0.0006423637,0.00006983692,0.0006575775,0.0001412909],"domain_scores_gemma":[0.99827915,0.00011970451,0.00076313096,0.00015077979,0.0005864243,0.000100822515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036213794,0.00011381907,0.00043183897,0.00012132021,0.000043693133,0.0000055319456,0.00022509029,0.000014680509,0.00023524057],"category_scores_gemma":[0.00010528665,0.00009499173,0.000072702125,0.00024368716,0.000047503654,0.00014078162,0.000025679605,0.0006665868,3.8481681e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001540709,0.00019503485,0.9780782,0.00024928115,0.0000851236,0.00003712577,0.0011686729,0.00017128963,0.008052825,0.000086852524,0.0009202727,0.010801264],"study_design_scores_gemma":[0.0021930016,0.00026571812,0.98207605,0.00043531143,0.00008107053,0.000008873832,0.004690924,0.00043064659,0.009538889,0.00013565567,0.00007365267,0.00007018588],"about_ca_topic_score_codex":0.050369445,"about_ca_topic_score_gemma":0.025762707,"teacher_disagreement_score":0.024606736,"about_ca_system_score_codex":0.0006160615,"about_ca_system_score_gemma":0.0011595029,"threshold_uncertainty_score":0.9920146},"labels":[],"label_agreement":null},{"id":"W2105397205","doi":"10.18553/jmcp.2005.11.6.480","title":"Consumer Understanding and Satisfaction Associated With a 3-Tier Prescription Drug Benefit","year":2005,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Merck Company Foundation","keywords":"Copayment; Medicine; Medical prescription; Prescription drug; Beneficiary; Formulary; Family medicine; Drug; Health care; Psychiatry; Pharmacology; Health insurance","score_opus":0.056430990078421256,"score_gpt":0.3168114739336097,"score_spread":0.2603804838551884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105397205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885563,0.0022180392,0.0023602769,0.0033049816,0.00014035394,0.00020032171,0.0000020442271,0.000021891887,0.0031957694],"genre_scores_gemma":[0.99705315,0.00066164724,0.0003376438,0.00073012157,0.00010882303,0.000002778765,0.0000033839117,0.000009549774,0.0010928841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992218,0.00003540686,0.00022632969,0.000087751636,0.0003220986,0.000106621235],"domain_scores_gemma":[0.9993055,0.00003792716,0.0002749438,0.00006800106,0.00018694071,0.00012667605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000199416,0.00008153731,0.0001683745,0.00011146163,0.000074939104,0.000025129051,0.00003792563,0.000018685354,0.00029458033],"category_scores_gemma":[0.000036097532,0.000062466126,0.000037418336,0.00010889126,0.00003810834,0.0002651774,0.000008626011,0.00026399613,0.0000134865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020028667,0.0002491954,0.634983,0.00042676434,0.0013326076,0.00023602563,0.005956785,0.00026048254,0.0069925915,0.00087186956,0.062136643,0.2845512],"study_design_scores_gemma":[0.037275843,0.0008445412,0.80505264,0.0040711937,0.0031920045,0.0015609072,0.027193297,0.004006089,0.005083125,0.0010677697,0.10987504,0.00077757397],"about_ca_topic_score_codex":0.000017481401,"about_ca_topic_score_gemma":0.000037397633,"teacher_disagreement_score":0.28377363,"about_ca_system_score_codex":0.0002661052,"about_ca_system_score_gemma":0.000056578094,"threshold_uncertainty_score":0.32254478},"labels":[],"label_agreement":null},{"id":"W2105612516","doi":"10.18553/jmcp.2009.15.4.312","title":"Direct All-Cause Health Care Costs Associated With Chronic Kidney Disease in Patients With Diabetes and Hypertension: A Managed Care Perspective","year":2009,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Diabetes mellitus; Kidney disease; Disease; Renal function; Managed care; Pediatrics; Intensive care medicine; Health care; Internal medicine; Endocrinology","score_opus":0.01142583061397372,"score_gpt":0.28017215693212655,"score_spread":0.2687463263181528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105612516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575274,0.037386414,9.517525e-7,0.0031002546,0.00009829637,0.001004804,0.00013690985,0.000053641204,0.00069131196],"genre_scores_gemma":[0.99351245,0.0006648562,0.000042750184,0.005263966,0.00017302805,0.00001178386,0.00025753456,0.000052769825,0.00002086474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974851,0.00024284226,0.000452008,0.00043085206,0.0007825868,0.00060660305],"domain_scores_gemma":[0.9967096,0.0000864969,0.00043496414,0.00029449724,0.0010205196,0.0014539075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016200411,0.00040015226,0.00082360825,0.00040785372,0.00016587491,0.00006476017,0.00015667343,0.000047132355,0.000031290627],"category_scores_gemma":[0.00027633534,0.0002891461,0.00016227174,0.00042623788,0.00009072411,0.00035276206,0.000046694702,0.0005738254,0.0000018385915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053041866,0.0010913518,0.9504327,0.001481207,0.0022550505,0.00234008,0.009528189,0.00008164026,0.000059373528,0.000015304278,0.007252303,0.020158576],"study_design_scores_gemma":[0.040249825,0.0035103983,0.9374109,0.0041390066,0.0028609813,0.0000070734022,0.0097022345,0.00006222703,0.00014674856,0.0000072748644,0.0014045923,0.0004987443],"about_ca_topic_score_codex":0.00006442436,"about_ca_topic_score_gemma":0.0000839222,"teacher_disagreement_score":0.036721557,"about_ca_system_score_codex":0.0033471396,"about_ca_system_score_gemma":0.001560859,"threshold_uncertainty_score":0.9999561},"labels":[],"label_agreement":null},{"id":"W2109257994","doi":"10.18553/jmcp.2006.12.7.537","title":"Assessing Potentially Inappropriate Prescribing in the Elderly Veterans Affairs Population Using the HEDIS 2006 Quality Measure","year":2006,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Health Services Research and Development; U.S. Department of Veterans Affairs","keywords":"Medicine; Beers Criteria; Veterans Affairs; Logistic regression; Medical Expenditure Panel Survey; Population; Family medicine; Emergency medicine; Health care; Gerontology; Geriatrics; Environmental health; Health insurance; Internal medicine; Psychiatry","score_opus":0.2019064082309326,"score_gpt":0.44626545093116937,"score_spread":0.24435904270023678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109257994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876021,0.0018954212,0.0030980369,0.0041386876,0.0005299188,0.00044846247,0.0000033270646,0.000013728937,0.0022702734],"genre_scores_gemma":[0.99795437,0.000053255575,0.00075699174,0.0005686028,0.0006211789,0.0000021073145,0.000009022243,0.00001906415,0.000015399497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676085,0.0011101037,0.0007905748,0.0001481058,0.0009216687,0.00026869535],"domain_scores_gemma":[0.99850374,0.0003247618,0.0006640637,0.00019751968,0.00024077343,0.00006916558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026096173,0.00017092828,0.0003151041,0.00014852072,0.00024165507,0.00024578263,0.0002593859,0.000043830052,0.000023947316],"category_scores_gemma":[0.00018415591,0.00009577239,0.0002524211,0.0003169387,0.00003922793,0.0009830528,0.000034924407,0.0010026525,0.0000011483032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034308794,0.001014173,0.6482883,0.0013745807,0.0005959509,0.0012929342,0.009267571,0.014848979,0.041239828,0.00035523466,0.0009433413,0.2773482],"study_design_scores_gemma":[0.023657117,0.0006271406,0.8668424,0.0016793158,0.004718737,0.0014098644,0.061057333,0.016913977,0.0025939362,0.0009783886,0.018583236,0.0009385489],"about_ca_topic_score_codex":0.0014120253,"about_ca_topic_score_gemma":0.000094333605,"teacher_disagreement_score":0.27640966,"about_ca_system_score_codex":0.00016250748,"about_ca_system_score_gemma":0.00007981176,"threshold_uncertainty_score":0.4356082},"labels":[],"label_agreement":null},{"id":"W2110607907","doi":"10.18553/jmcp.2005.11.9.746","title":"Product-Line Extensions and Pricing Strategies of Brand-Name Drugs Facing Patent Expiration","year":2005,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Generic drug; Prescription drug; Medicine; Marketing; Medical prescription; Brand extension; Brand loyalty; Product (mathematics); Advertising; Market share; Brand names; Panel data; Expiration date; Drug; Business; Brand management; Economics; Pharmacology","score_opus":0.09298290153023488,"score_gpt":0.3140020313484577,"score_spread":0.22101912981822286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110607907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755655,0.01302233,0.0014713551,0.0032047313,0.0002963997,0.00016492109,0.00003547054,0.0000099988665,0.006229299],"genre_scores_gemma":[0.9952087,0.0030825508,0.00067724264,0.00053156883,0.00042944483,0.0000020826208,0.0000028605746,0.000016453261,0.00004913833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860704,0.000025571078,0.0009383155,0.00018084976,0.000049756167,0.00019844608],"domain_scores_gemma":[0.9988198,0.00005677009,0.00076046796,0.00012845831,0.000110818226,0.00012366462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057586475,0.00013559629,0.00041282902,0.00028960436,0.000084671854,0.00008083024,0.00015050893,0.000025040863,0.00010566021],"category_scores_gemma":[0.000052998523,0.00013693584,0.00012577434,0.00010856601,0.000044698652,0.00069184403,0.000056199162,0.00026609583,0.000015972784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087920274,0.00092027424,0.039243426,0.0019065789,0.0014108093,0.00007998451,0.048389185,0.07970852,0.020328872,0.1835191,0.0051006945,0.61851335],"study_design_scores_gemma":[0.02876414,0.0009534616,0.031152409,0.0006432354,0.00064103166,0.00037093606,0.018596252,0.09633659,0.07075662,0.07037943,0.6787976,0.0026083176],"about_ca_topic_score_codex":0.00004496575,"about_ca_topic_score_gemma":0.000007299803,"teacher_disagreement_score":0.6736969,"about_ca_system_score_codex":0.000097892975,"about_ca_system_score_gemma":0.000040811214,"threshold_uncertainty_score":0.55840814},"labels":[],"label_agreement":null},{"id":"W2112369566","doi":"10.18553/jmcp.2005.11.1.25","title":"The Impact of Chronic Obstructive Pulmonary Disease on Long-term Disability Costs","year":2005,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; COPD; Spirometry; Asthma; Population; Disability benefits; Health care; Environmental health; Physical therapy; Gerontology; Economic growth; Social security","score_opus":0.02205235405781437,"score_gpt":0.36751747414525054,"score_spread":0.3454651200874362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112369566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800012,0.014896318,0.000011608912,0.0016339971,0.00025808418,0.0008101846,0.000099236546,0.000019340901,0.002270004],"genre_scores_gemma":[0.9971766,0.001142642,0.000020339277,0.000050556475,0.0013258395,0.000015029862,0.000021856455,0.000048040496,0.00019911013],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968898,0.00035236884,0.00073477183,0.0003206267,0.0011555485,0.0005468742],"domain_scores_gemma":[0.9969131,0.000407466,0.00051423407,0.0006694287,0.0006798652,0.0008159511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004909749,0.00032402508,0.00051686825,0.00017350863,0.0002218542,0.00004339263,0.00053906697,0.00003555234,0.0004777847],"category_scores_gemma":[0.00024505844,0.00020558838,0.00094139116,0.00034005515,0.00061222445,0.00038100453,0.00016364173,0.0009750961,0.000024463698],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008124379,0.0012062467,0.48039988,0.0007222168,0.000663809,0.0015052719,0.00015028047,0.00083424884,0.0010256426,0.000040304953,0.0005744557,0.50475323],"study_design_scores_gemma":[0.003200034,0.00032622844,0.9924889,0.0003016523,0.00041564213,0.00025799434,0.0003088236,0.0008581828,0.00087146513,0.00006917272,0.00072394055,0.00017794511],"about_ca_topic_score_codex":0.0000564325,"about_ca_topic_score_gemma":0.000015847907,"teacher_disagreement_score":0.512089,"about_ca_system_score_codex":0.0058780974,"about_ca_system_score_gemma":0.001012648,"threshold_uncertainty_score":0.99793816},"labels":[],"label_agreement":null},{"id":"W2117516569","doi":"10.18553/jmcp.2007.13.8.677","title":"Factors Associated With Choice of Pharmacy Setting Among DoD Health Care Beneficiaries Aged 65 Years or Older","year":2007,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Machine Intelligence Institute; U.S. Department of Defense","keywords":"Medicine; Pharmacy; Gerontology; Family medicine; Health care","score_opus":0.07854000265562466,"score_gpt":0.39070662985506566,"score_spread":0.312166627199441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117516569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501806,0.0026829273,0.0003399276,0.00062562386,0.00027499543,0.00039904367,0.000014998955,0.00003757845,0.0006068564],"genre_scores_gemma":[0.99793804,0.00015614476,0.00023551963,0.0010647017,0.0002472336,0.0000029808411,0.0000365837,0.00003459999,0.0002841783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975765,0.00013102284,0.0008298838,0.00019279512,0.00088108133,0.00038875054],"domain_scores_gemma":[0.99707955,0.0003030269,0.0013801515,0.00019535162,0.0006728204,0.00036910665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007310686,0.00021823011,0.00058812514,0.00028673635,0.00013860509,0.000026247064,0.00026213317,0.000040179122,0.00040724597],"category_scores_gemma":[0.0003008759,0.00015559561,0.00016099111,0.00051018264,0.00008073652,0.00025259153,0.000035625235,0.0007365144,0.000004391571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009497577,0.0002587226,0.90459174,0.000991794,0.00071787153,0.00047036668,0.018418226,0.00007518806,0.000994762,0.000006363871,0.005666455,0.06685874],"study_design_scores_gemma":[0.010506227,0.00040448923,0.93852144,0.0016637207,0.0005053159,0.000032357068,0.032272775,0.000036232912,0.007819596,0.0000025354284,0.007985664,0.00024962288],"about_ca_topic_score_codex":0.00019444093,"about_ca_topic_score_gemma":0.00029827928,"teacher_disagreement_score":0.06660912,"about_ca_system_score_codex":0.0003047222,"about_ca_system_score_gemma":0.0005546552,"threshold_uncertainty_score":0.63450044},"labels":[],"label_agreement":null},{"id":"W2134015462","doi":"10.18553/jmcp.2007.13.3.245","title":"Cost-effectiveness of Four Immunomodulatory Therapies for Relapsing-Remitting Multiple Sclerosis: A Markov Model Based on Long-term Clinical Data","year":2007,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Glatiramer acetate; Multiple sclerosis; Expanded Disability Status Scale; Cohort; Internal medicine; Relapsing remitting; Disease; Physical therapy; Immunology","score_opus":0.3435434485136205,"score_gpt":0.46697527217032236,"score_spread":0.12343182365670186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134015462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9180165,0.00478057,0.07352003,0.00032398212,0.00064585544,0.002349524,0.00012295351,0.00003775838,0.00020280271],"genre_scores_gemma":[0.9865612,0.0015070732,0.0110494,0.0002636711,0.0004538224,0.000029979252,0.000043670152,0.00007262746,0.000018577859],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99604225,0.0005837018,0.001378113,0.0004431965,0.0010208294,0.0005319115],"domain_scores_gemma":[0.9917755,0.00488507,0.0009042944,0.00085596944,0.0012980107,0.00028112996],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010868259,0.00031107015,0.0010013967,0.00047376752,0.00021285767,0.000037902882,0.000743517,0.00009421882,0.000013146199],"category_scores_gemma":[0.0034276717,0.00024954585,0.00056961563,0.00024365718,0.00021979246,0.0003407653,0.00027785875,0.0009687726,0.0000014696577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030731231,0.0011083995,0.37435484,0.002843067,0.001810213,0.00012537585,0.00057644874,0.002429022,0.049884982,0.0000027738058,0.0009980496,0.5351356],"study_design_scores_gemma":[0.033357173,0.0009836617,0.8516594,0.005086787,0.00068762625,0.000021746486,0.00074994465,0.09659303,0.010214069,0.000008007745,0.00033061075,0.00030791629],"about_ca_topic_score_codex":0.000015386995,"about_ca_topic_score_gemma":0.000013374681,"teacher_disagreement_score":0.5348277,"about_ca_system_score_codex":0.00032615717,"about_ca_system_score_gemma":0.00031893628,"threshold_uncertainty_score":0.99999565},"labels":[],"label_agreement":null},{"id":"W2136365330","doi":"10.18553/jmcp.2002.8.5.372","title":"Preventable Drug-related Morbidity Indicators in the U.S. and U.K.","year":2002,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Medicine, Dalhousie University; Dalhousie University","keywords":"Delphi method; Medicine; Viewpoints; Relevance (law); Health care; Quality (philosophy); Delphi; Sample (material); Pharmacy; Family medicine; Statistics; Political science","score_opus":0.09606945741123855,"score_gpt":0.3869771716405904,"score_spread":0.29090771422935185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136365330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691433,0.009204601,0.0000031078346,0.007283653,0.00024482745,0.00027844365,0.0000017626281,0.000007576747,0.013832779],"genre_scores_gemma":[0.9942273,0.0032799738,0.00005650193,0.001956151,0.0000935943,0.0000021474705,0.0000012129026,0.000009300496,0.00037380026],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874896,0.0002394651,0.00038265545,0.00009281033,0.00036758694,0.00016850705],"domain_scores_gemma":[0.99922365,0.00023685653,0.00025840278,0.000107426604,0.00004211869,0.00013154448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006653743,0.0001018714,0.00022634567,0.00027677248,0.00006253915,0.000027385922,0.00014894619,0.000022255303,0.000463938],"category_scores_gemma":[0.00009448686,0.0000629867,0.000098159784,0.00040079094,0.000044876702,0.00029062273,0.00003533642,0.00078568247,0.000013840785],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048416853,0.00081080693,0.83254457,0.00053099514,0.00037763445,0.0016654398,0.013264147,0.00003783689,0.00034392747,0.00015868705,0.027850378,0.12193138],"study_design_scores_gemma":[0.019308843,0.0004008856,0.19888875,0.00034931218,0.0016098652,0.0016565,0.0075200577,0.0021759537,0.0015003512,0.0002827789,0.765948,0.00035872933],"about_ca_topic_score_codex":0.000021653723,"about_ca_topic_score_gemma":0.0000029172982,"teacher_disagreement_score":0.7380976,"about_ca_system_score_codex":0.000051865452,"about_ca_system_score_gemma":0.000016548196,"threshold_uncertainty_score":0.5079796},"labels":[],"label_agreement":null},{"id":"W2141292679","doi":"10.18553/jmcp.2006.12.5.371","title":"Effect of a Therapeutic Maximum Allowable Cost (MAC) Program on the Cost and Utilization of Proton Pump Inhibitors in an Employer-Sponsored Drug Plan in Canada","year":2006,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fraser Health; Royal Columbian Hospital","funders":"","keywords":"Medicine; Plan (archaeology); Drug; Operations management; Actuarial science; Pharmacology; Engineering; Business","score_opus":0.1770856332218254,"score_gpt":0.4106357295729452,"score_spread":0.23355009635111978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141292679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269253,0.0013737567,0.000019478419,0.002306142,0.00018713364,0.0030762292,0.00006230779,0.0000053115523,0.00027712726],"genre_scores_gemma":[0.99905753,0.00013995949,0.0000346764,0.00048318107,0.0000714082,0.00016677132,0.000014009981,0.000021711261,0.000010741332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99574995,0.0010685036,0.002556098,0.00020510801,0.00016986796,0.00025045488],"domain_scores_gemma":[0.9965292,0.00091931294,0.0021826336,0.00020098273,0.000086935564,0.00008089626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009505679,0.00016278715,0.0007482866,0.00045067765,0.000057466714,0.00003700504,0.0002492324,0.000037738373,0.000030382373],"category_scores_gemma":[0.00032118039,0.00014679492,0.000069430316,0.00028454696,0.000047159247,0.00031179018,0.000022817581,0.00028535296,0.0000019112179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072039844,0.0002877299,0.9758402,0.0014734528,0.000063623076,0.000015414807,0.0022138439,0.0037183862,0.000053730324,0.0005981386,0.0010553194,0.01395978],"study_design_scores_gemma":[0.02757522,0.0028141893,0.83798695,0.0023186912,0.00015280258,0.000045028955,0.013903373,0.039879363,0.017505985,0.0036599706,0.052851684,0.0013067332],"about_ca_topic_score_codex":0.21212144,"about_ca_topic_score_gemma":0.23321427,"teacher_disagreement_score":0.13785322,"about_ca_system_score_codex":0.00090452563,"about_ca_system_score_gemma":0.00037148249,"threshold_uncertainty_score":0.7931251},"labels":[],"label_agreement":null},{"id":"W2143960546","doi":"10.18553/jmcp.2004.10.6.531","title":"Cost-Minimization Analysis of Once-Weekly Versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia","year":2004,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Dosing; Anemia; Epoetin alfa; Confidence interval; Regimen; Total cost; Emergency medicine; Internal medicine","score_opus":0.04392539738589477,"score_gpt":0.3600504343334252,"score_spread":0.3161250369475304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143960546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708226,0.0048945453,0.0027198044,0.014674746,0.0008918267,0.0013113065,0.000054861426,0.000060232065,0.004570125],"genre_scores_gemma":[0.9907953,0.0024473572,0.0056383563,0.0003732257,0.00020406957,0.000012056143,0.00011201149,0.00003533834,0.00038229857],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99812746,0.000060578222,0.00083232153,0.00021997561,0.0004959458,0.00026371455],"domain_scores_gemma":[0.997898,0.00016560146,0.0008383816,0.000231513,0.0006693393,0.00019718242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003003939,0.00023761939,0.00075183564,0.0005442947,0.0000917954,0.00002088661,0.00017365607,0.00008427326,0.00028707797],"category_scores_gemma":[0.00009520903,0.00019457875,0.00071272394,0.0008980719,0.00007799704,0.0001406977,0.000020701955,0.00029814805,0.000005009412],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044806577,0.006565705,0.029052384,0.002890421,0.05057211,0.0020662104,0.031094616,0.07601753,0.035178475,0.0009429543,0.027492326,0.6933207],"study_design_scores_gemma":[0.41683164,0.013615068,0.03612943,0.002411254,0.107038185,0.00059787964,0.0422989,0.005751735,0.22166575,0.00046802592,0.15110041,0.002091724],"about_ca_topic_score_codex":0.00005196275,"about_ca_topic_score_gemma":0.0000141159635,"teacher_disagreement_score":0.691229,"about_ca_system_score_codex":0.00048470756,"about_ca_system_score_gemma":0.00022430555,"threshold_uncertainty_score":0.7934691},"labels":[],"label_agreement":null},{"id":"W2144636396","doi":"10.18553/jmcp.2009.15.s1.18","title":"The Future of Medicare Part D Drug Plans—Results From a Roundtable Discussion","year":2009,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada","funders":"","keywords":"Prescription drug; Medicare Part D; Beneficiary; Medicine; Government (linguistics); Sustainability; Health care; Modernization theory; Medicare Advantage; Population; Medicaid; Actuarial science; Patient Protection and Affordable Care Act; Medical prescription; Public economics; Finance; Business; Economic growth; Environmental health; Economics; Nursing","score_opus":0.02795174814693361,"score_gpt":0.33255021275584884,"score_spread":0.3045984646089152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144636396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50709105,0.058186248,0.0011343063,0.4057699,0.005710749,0.0010082906,0.00019543203,0.0000763793,0.020827668],"genre_scores_gemma":[0.98561776,0.0044625886,0.0002314022,0.0017505098,0.0018176147,0.0000024389133,0.000036942813,0.000008418667,0.006072342],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982347,0.000105376304,0.00063606404,0.00012752041,0.0007273204,0.00016902099],"domain_scores_gemma":[0.9984619,0.0001224202,0.00060799014,0.00029159506,0.00030398936,0.00021210208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047746173,0.000117824944,0.00029765765,0.00006021184,0.00012059888,0.000033529086,0.00033933212,0.000030088337,0.00018772515],"category_scores_gemma":[0.00010548972,0.00005545676,0.00015223617,0.00017244136,0.000038372433,0.00022605671,0.000021891141,0.00048308374,0.00002196124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002169724,0.0001098514,0.002662111,0.00007432139,0.00017994795,0.00021936375,0.003026579,0.000014529534,0.0013451928,0.00010570136,0.47886708,0.5112256],"study_design_scores_gemma":[0.006377209,0.00017741702,0.009312981,0.00084138656,0.00028203576,0.00006898953,0.0139374025,0.00007297002,0.0029596358,0.00052464503,0.9653351,0.00011024968],"about_ca_topic_score_codex":0.000023418712,"about_ca_topic_score_gemma":0.000012641861,"teacher_disagreement_score":0.5111153,"about_ca_system_score_codex":0.000073078685,"about_ca_system_score_gemma":0.00017515705,"threshold_uncertainty_score":0.2261461},"labels":[],"label_agreement":null},{"id":"W2151986070","doi":"10.18553/jmcp.2003.9.2.134","title":"Indicators of Preventable Drug-related Morbidity in Older Adults","year":2003,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Logistic regression; Medical prescription; Incidence (geometry); Health care; Environmental health; Nursing; Internal medicine","score_opus":0.044766617435349744,"score_gpt":0.3840983321694234,"score_spread":0.33933171473407364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151986070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98526156,0.0038620043,0.000012174413,0.0004634253,0.00048260184,0.00037430905,0.0000034041543,0.0000079329875,0.0095326],"genre_scores_gemma":[0.9982403,0.0008691529,0.00021349128,0.00035174136,0.000040997827,0.0000023231246,0.0000030902706,0.000016799919,0.00026209175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817693,0.00028270844,0.0007436936,0.00012518869,0.00045308936,0.00021837188],"domain_scores_gemma":[0.99871725,0.00017907449,0.0006190419,0.00013635452,0.00013738616,0.0002108801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007296675,0.00013519847,0.00042006213,0.00040407534,0.000029138091,0.000007791133,0.00013553031,0.000037552472,0.0006924868],"category_scores_gemma":[0.00023412012,0.00010830934,0.00020095526,0.0004822923,0.000039577706,0.0003064961,0.000027671442,0.00073887844,0.000009112704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015267251,0.0012314138,0.9654573,0.0012248062,0.0003926507,0.00058817887,0.0041784626,0.00010167267,0.0006454267,0.00013900499,0.0028539633,0.021660365],"study_design_scores_gemma":[0.092662774,0.0008595998,0.5725388,0.0035390605,0.0029457489,0.0007934453,0.013865627,0.00062639214,0.11922292,0.0003772242,0.19168258,0.00088583474],"about_ca_topic_score_codex":0.00004931454,"about_ca_topic_score_gemma":0.000004920723,"teacher_disagreement_score":0.39291853,"about_ca_system_score_codex":0.00010947692,"about_ca_system_score_gemma":0.00012277694,"threshold_uncertainty_score":0.7582245},"labels":[],"label_agreement":null},{"id":"W2154125954","doi":"10.18553/jmcp.2014.20.5.477","title":"Adherence Patterns for Abiraterone Acetate and Concomitant Prednisone Use in Patients with Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Abiraterone acetate; Prednisone; Concomitant; Prostate cancer; Internal medicine; Medical prescription; Population; Cancer; Androgen deprivation therapy; Oncology; Pharmacology","score_opus":0.03293191264913797,"score_gpt":0.33480896597467863,"score_spread":0.30187705332554066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154125954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972142,0.00092281116,0.000084572544,0.0006515638,0.00012220522,0.0009139268,0.000057085443,0.0000069357484,0.000026728592],"genre_scores_gemma":[0.99804235,0.00101842,0.00028320486,0.00018381662,0.00008924377,0.00005009029,0.000016632954,0.000024189854,0.0002920303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895257,0.00006563885,0.00028527115,0.0001573403,0.00028602144,0.0002531733],"domain_scores_gemma":[0.9990543,0.00006963189,0.00020277935,0.000098092045,0.00041495886,0.00016023013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020423665,0.00013948497,0.0003261949,0.0001409111,0.000046815312,0.00004761273,0.00007282113,0.000019317276,0.000021072907],"category_scores_gemma":[0.000026540443,0.00008775423,0.000044630073,0.00008927887,0.000049186594,0.00029333294,0.000029686942,0.00022638962,6.8124376e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010588148,0.00012498767,0.93874764,0.0005250081,0.00017977023,0.000063305706,0.0012442541,0.000025892816,0.00046583798,0.0000015682439,0.00031490982,0.047718674],"study_design_scores_gemma":[0.05821356,0.0028711234,0.928286,0.000977227,0.00030609494,0.000012818904,0.0004339764,0.00020807423,0.0042281486,0.000015774976,0.0042705014,0.0001766814],"about_ca_topic_score_codex":0.00012124373,"about_ca_topic_score_gemma":0.000083742765,"teacher_disagreement_score":0.04762541,"about_ca_system_score_codex":0.00015925044,"about_ca_system_score_gemma":0.00009408437,"threshold_uncertainty_score":0.35785136},"labels":[],"label_agreement":null},{"id":"W2158467616","doi":"10.18553/jmcp.2009.15.1.71","title":"Prior Authorization and Clopidogrel Use - The Truth Lies in the Details","year":2009,"lang":"en","type":"editorial","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prior authorization; Clopidogrel; Authorization; Internal medicine; Aspirin; Pharmacology; Computer security","score_opus":0.05385844944678472,"score_gpt":0.3197232124911843,"score_spread":0.26586476304439954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158467616","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03124028,0.05253344,0.00031337282,0.016662216,0.88743496,0.0011104299,0.0008221558,0.000028917637,0.009854214],"genre_scores_gemma":[0.4369858,0.053548843,0.00016879682,0.00288838,0.50592405,0.000019202704,0.000063988395,0.000085257816,0.00031571102],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790233,0.0001565038,0.0012079203,0.00027551185,0.00013479362,0.0003229088],"domain_scores_gemma":[0.99661416,0.0015780246,0.0013169231,0.00027424181,0.000112040994,0.00010461398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019628897,0.0002845623,0.00064751157,0.0004098383,0.00017954854,0.00058338,0.0008236442,0.00019234439,0.000042043863],"category_scores_gemma":[0.0011118856,0.00020262667,0.00025237497,0.0002441915,0.00008574245,0.0005219303,0.000084276355,0.0017040018,0.000023689281],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017520897,0.00008025629,0.0011198791,0.00016513235,0.00020319983,0.000060726812,0.0033857767,0.00012032579,0.000001467425,0.021850655,0.9469799,0.025857503],"study_design_scores_gemma":[0.0014222512,0.00006541727,0.0015704482,0.00004936501,0.000087904235,0.000011814991,0.00022244912,0.00028062845,0.0000047764665,0.0057078763,0.9903445,0.0002325207],"about_ca_topic_score_codex":0.00009692713,"about_ca_topic_score_gemma":0.00003036707,"teacher_disagreement_score":0.4057455,"about_ca_system_score_codex":0.0001934534,"about_ca_system_score_gemma":0.00010867868,"threshold_uncertainty_score":0.8262876},"labels":[],"label_agreement":null},{"id":"W2162799816","doi":"10.18553/jmcp.2007.13.3.262","title":"Actuarial Analysis of Private Payer Administrative Claims Data for Women With Endometriosis","year":2007,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Endometriosis; Diagnosis code; Pelvic pain; Referral; Health care; Retrospective cohort study; Medical record; Family medicine; Demography; Environmental health; Gynecology; Population; Internal medicine; Surgery","score_opus":0.1022879110438829,"score_gpt":0.43469814236562404,"score_spread":0.33241023132174113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162799816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893897,0.0012018946,0.006267863,0.00048871763,0.00011364149,0.0009076981,0.00028936216,0.000011381084,0.0013297533],"genre_scores_gemma":[0.99379194,0.00086142233,0.0047685895,0.0001017448,0.0002307149,0.000014342164,0.00010237363,0.000021856991,0.000107030246],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975932,0.00008592489,0.00069637573,0.00024408317,0.000948662,0.0004317529],"domain_scores_gemma":[0.9951479,0.0025209403,0.00062216714,0.0004963005,0.0007706562,0.0004420341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001727801,0.00018935993,0.00087588676,0.0021054063,0.00006908307,0.000031465013,0.00041436253,0.000034838766,0.00019712935],"category_scores_gemma":[0.001627432,0.00012060676,0.00028036063,0.002428466,0.000073394185,0.0002701343,0.00009650542,0.00031920566,0.0000013008535],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12863605,0.003770076,0.12390749,0.0014695894,0.12586682,0.0038733422,0.0059734564,0.000114893715,0.019995896,0.00017493725,0.003256239,0.5829612],"study_design_scores_gemma":[0.14672786,0.028908297,0.1824704,0.0005269127,0.047647852,0.00044653122,0.022283666,0.00046234456,0.23568171,0.00013964508,0.3336985,0.0010062648],"about_ca_topic_score_codex":0.00001991254,"about_ca_topic_score_gemma":0.00004155373,"teacher_disagreement_score":0.58195496,"about_ca_system_score_codex":0.00038442464,"about_ca_system_score_gemma":0.00028405545,"threshold_uncertainty_score":0.4918201},"labels":[],"label_agreement":null},{"id":"W2180208706","doi":"10.18553/jmcp.2012.18.5.363","title":"All-Cause and Potentially Disease-Related Health Care Costs Associated with Venous Thromboembolism in Commercial, Medicare, and Medicaid Beneficiaries","year":2012,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"University of Illinois at Chicago; University of Illinois at Urbana-Champaign; Janssen Scientific Affairs","keywords":"Medicine; Pulmonary embolism; Medicaid; Diagnosis code; Venous thrombosis; Deep vein; Disease; Pediatrics; Thrombosis; Intensive care medicine; Health care; Emergency medicine; Surgery; Internal medicine; Population","score_opus":0.022788755898265893,"score_gpt":0.31959373641083144,"score_spread":0.29680498051256554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2180208706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9243179,0.06384765,0.000022587585,0.009793858,0.0005179086,0.0007802487,0.000031539526,0.00004195142,0.0006463798],"genre_scores_gemma":[0.978845,0.017130597,0.00012872067,0.0034962238,0.00024373397,0.000013050676,0.00007868239,0.00005617232,0.000007832986],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99720967,0.00028486154,0.00076098274,0.0002507862,0.0008628949,0.00063079374],"domain_scores_gemma":[0.99777764,0.00014233404,0.0006051973,0.00021066098,0.00029067922,0.00097347365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088710245,0.00031977953,0.0011610282,0.00040575405,0.00020896175,0.00006039515,0.00016755989,0.00007932091,0.000056657344],"category_scores_gemma":[0.00017461681,0.0002543691,0.00010560934,0.00028386526,0.00016664047,0.00037082963,0.00014529609,0.00069799926,0.0000018701156],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022493969,0.006354671,0.4000458,0.0037138383,0.012433508,0.005125194,0.11240344,0.00013354268,0.000119177595,0.0025666235,0.02930519,0.4255496],"study_design_scores_gemma":[0.009905388,0.00081568054,0.9590764,0.0017843685,0.0035714596,0.00016830838,0.014047214,0.00002587174,0.000026361573,0.00003869992,0.010187476,0.00035277614],"about_ca_topic_score_codex":0.0005307305,"about_ca_topic_score_gemma":0.00059295184,"teacher_disagreement_score":0.5590306,"about_ca_system_score_codex":0.0004911643,"about_ca_system_score_gemma":0.0003130534,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W2187411263","doi":"10.18553/jmcp.2010.16.9.680","title":"Evaluation of Health Plan Member Use of an Online Prescription Drug Price Comparison Tool","year":2010,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Copayment; Medicine; Pharmacy; Quarter (Canadian coin); Medical prescription; Prescription drug; Family medicine; Demographics; Health care; Demography; Nursing","score_opus":0.28205228986199204,"score_gpt":0.45511176631584055,"score_spread":0.1730594764538485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187411263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965896,0.00076370226,0.00035771704,0.0010568233,0.00045685307,0.0004103778,0.000011254536,0.000008564092,0.00034508153],"genre_scores_gemma":[0.99595684,0.00014080304,0.0031314422,0.00038678615,0.00017586142,0.0000036369872,0.000042138785,0.000009687267,0.00015282109],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973809,0.00034226032,0.00085421756,0.00010639431,0.0012020281,0.00011418272],"domain_scores_gemma":[0.99671847,0.000054565357,0.0012671978,0.00024368051,0.0015799196,0.00013614411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002227465,0.0000909563,0.00037217766,0.00016030502,0.000035444868,0.000010287592,0.0001513112,0.000025559028,0.00057568133],"category_scores_gemma":[0.00029262438,0.000075343894,0.00009914716,0.0001558741,0.00003920954,0.00035622218,0.000017372719,0.00046544312,0.000005827019],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012649586,0.0024978314,0.06485761,0.0014895421,0.00051369274,0.00001432442,0.008306157,0.0016811417,0.09164143,0.00009084297,0.039762203,0.78788024],"study_design_scores_gemma":[0.026188528,0.0020165555,0.64754826,0.0021610102,0.0033879804,0.00036422932,0.012433063,0.12390384,0.05496053,0.00027024673,0.1262515,0.0005142453],"about_ca_topic_score_codex":0.00012946219,"about_ca_topic_score_gemma":0.000045160177,"teacher_disagreement_score":0.78736603,"about_ca_system_score_codex":0.00007412072,"about_ca_system_score_gemma":0.00047333253,"threshold_uncertainty_score":0.6303307},"labels":[],"label_agreement":null},{"id":"W2188680388","doi":"10.18553/jmcp.2003.9.6.523","title":"Financial Risk Relationships and Adoption of Management Strategies in Physician Groups for Self-Administered Injectable Drugs","year":2003,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"AcademyHealth; Robert Wood Johnson Foundation","keywords":"Capitation; Medicine; Pharmacy; Family medicine; Health maintenance; Risk management; Financial risk; Finance; Health care; Business","score_opus":0.03690324769388929,"score_gpt":0.32261147775706933,"score_spread":0.28570823006318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188680388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835353,0.0014305646,0.003267201,0.00022031814,0.00017326805,0.000542682,0.0000048659217,0.000010657231,0.010815183],"genre_scores_gemma":[0.99309236,0.0009182485,0.0055928873,0.00015066283,0.000070804366,0.000018086046,0.000004697025,0.000008060193,0.00014417927],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990393,0.00011632848,0.0004108799,0.00010469089,0.00021082013,0.000117969495],"domain_scores_gemma":[0.99917763,0.00006985012,0.0004241,0.000101849684,0.00016880299,0.000057735437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054988055,0.00008783409,0.00022905706,0.0001777773,0.00006396622,0.000015556196,0.00006929381,0.000025262738,0.000017127068],"category_scores_gemma":[0.000059857874,0.0000801694,0.00006839822,0.00020549947,0.000024453058,0.00021715385,0.000010301188,0.0002638124,0.000003760299],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071059046,0.0033186432,0.37090626,0.015861573,0.0013830062,0.00038580442,0.043979812,0.0009799754,0.0032563924,0.15495189,0.025017202,0.37285355],"study_design_scores_gemma":[0.05100201,0.0022646952,0.58904773,0.0031750575,0.0027721566,0.00017520276,0.18378215,0.001425125,0.0056051672,0.03465796,0.125243,0.00084972876],"about_ca_topic_score_codex":0.0000043391924,"about_ca_topic_score_gemma":0.0000034446925,"teacher_disagreement_score":0.37200382,"about_ca_system_score_codex":0.000060704002,"about_ca_system_score_gemma":0.00012222918,"threshold_uncertainty_score":0.3269213},"labels":[],"label_agreement":null},{"id":"W2189198699","doi":"10.18553/jmcp.2003.9.4.353","title":"The Economic Impact of Acute Exacerbations of Chronic Bronchitis in the United States and Canada: A Literature Review","year":2003,"lang":"en","type":"review","venue":"Journal of Managed Care Pharmacy","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"GlaxoSmithKline","keywords":"Chronic bronchitis; Medicine; Bronchitis; Intensive care medicine; Public health; MEDLINE; Health care; Health economics; Pharmacoeconomics; Internal medicine; Nursing","score_opus":0.01324600114464602,"score_gpt":0.32041036808875645,"score_spread":0.3071643669441104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189198699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012221275,0.99762565,0.0000013446287,0.00013484043,0.00024394787,0.0003732131,0.00031291097,0.0000010287287,0.000084924744],"genre_scores_gemma":[0.0015748902,0.9980071,0.000002445745,0.000080208556,0.000029385337,0.0000025049137,0.00013058033,0.000012743902,0.00016012127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979587,0.00085945043,0.0008466427,0.000104452374,0.000048427566,0.00018233524],"domain_scores_gemma":[0.9980646,0.00038284896,0.0011981399,0.00021742606,0.0001187883,0.000018216419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048480878,0.00021568539,0.001017608,0.00014868694,0.00009758091,0.000015069696,0.00044137787,0.000078744444,0.0000438539],"category_scores_gemma":[0.000020541569,0.00010141398,0.00038358042,0.00023503765,0.0001307484,0.000050841434,0.000032853237,0.0007794997,9.3360836e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015525876,0.000091323825,0.00014282785,0.10568856,0.013920608,0.00043605233,0.0016674612,0.00008619754,0.00003198096,0.00030717527,0.2056342,0.67183834],"study_design_scores_gemma":[0.00060042605,0.00008918136,0.000045191755,0.03177663,0.002010675,0.0006434989,0.00015633921,6.1521826e-7,0.000006630143,0.0000049330997,0.9645644,0.00010152662],"about_ca_topic_score_codex":0.018638968,"about_ca_topic_score_gemma":0.026258074,"teacher_disagreement_score":0.75893015,"about_ca_system_score_codex":0.0004997348,"about_ca_system_score_gemma":0.0019305412,"threshold_uncertainty_score":0.99151015},"labels":[],"label_agreement":null},{"id":"W2274300369","doi":"10.18553/jmcp.2007.13.9-c.1","title":"The Changing Landscape of Type 2 Diabetes: The Role of Incretin-Based Therapies in Managed Care Outcomes","year":2007,"lang":"en","type":"review","venue":"Journal of Managed Care Pharmacy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; McGill University; U.S. Department of Veterans Affairs; University of Southern California; Eli Lilly and Company; American Diabetes Association","keywords":"Medicine; Incretin; Intensive care medicine; Exenatide; Type 2 Diabetes Mellitus; Disease; Diabetes mellitus; Type 2 diabetes; Postprandial; Sitagliptin; Bioinformatics; Internal medicine; Endocrinology","score_opus":0.030240095817671963,"score_gpt":0.34629571035188284,"score_spread":0.3160556145342109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274300369","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006201219,0.9888512,0.0000021572398,0.00021380496,0.0004034214,0.0011751744,0.00001289901,0.000013939999,0.0031261842],"genre_scores_gemma":[0.11158165,0.88767415,0.00007173323,0.00017562011,0.00017564026,0.00002709732,0.00004023102,0.000064664244,0.00018918232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970887,0.00037529945,0.0011913535,0.00019588452,0.000699956,0.00044885013],"domain_scores_gemma":[0.9967271,0.0008675345,0.0014449595,0.00050073577,0.0003776194,0.00008206421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014739792,0.00043721884,0.00186269,0.0009929185,0.00011429689,0.000037188962,0.0006642865,0.00008511435,0.000046326764],"category_scores_gemma":[0.00010244754,0.00021475083,0.00097038195,0.00085609156,0.00010563852,0.0000706092,0.00014443988,0.0006833042,0.0000044388066],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012464925,0.00008784166,0.0100718755,0.012206207,0.0022104308,0.00007878405,0.0018427891,0.000011865512,0.0000025843697,0.000047055037,0.00023375265,0.9730822],"study_design_scores_gemma":[0.002576104,0.00028232168,0.00065814715,0.009045274,0.0053569633,0.0000033465603,0.012764999,0.000021089527,0.00008946166,0.000016208704,0.9689697,0.00021635686],"about_ca_topic_score_codex":0.000015549755,"about_ca_topic_score_gemma":0.000017375572,"teacher_disagreement_score":0.9728658,"about_ca_system_score_codex":0.00019341249,"about_ca_system_score_gemma":0.00017356506,"threshold_uncertainty_score":0.8757285},"labels":[],"label_agreement":null},{"id":"W2275784987","doi":"10.18553/jmcp.2007.13.7.589","title":"Perceptions of Saskatchewan Community Pharmacists Regarding a Prior-Authorization Program","year":2007,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Pharmacy; Pharmacist; Family medicine; Medical prescription; Prior authorization; Authorization; Nursing","score_opus":0.12258614385582679,"score_gpt":0.46141677899021105,"score_spread":0.3388306351343843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275784987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98788494,0.00058249634,0.0036822944,0.0004945139,0.0005414037,0.0006053365,0.000006768313,0.00005006564,0.006152172],"genre_scores_gemma":[0.9948115,0.000294145,0.0039206753,0.00045020724,0.00030363403,0.0000028844336,0.00001687101,0.000025415104,0.00017469694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978661,0.00034341094,0.00082024746,0.000101430785,0.0006000968,0.00026871418],"domain_scores_gemma":[0.99770117,0.00037813754,0.00071663316,0.00019862024,0.0006840995,0.00032132195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019262984,0.00016634971,0.00041933404,0.00032317862,0.00021178606,0.00002746405,0.00022054647,0.00004744555,0.00017469714],"category_scores_gemma":[0.0002528041,0.00013849247,0.00032315758,0.0004082388,0.00008512244,0.000431739,0.00007253215,0.0013243787,0.000006240707],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038307644,0.0019090675,0.18574949,0.001719332,0.0007053715,0.00037516668,0.021605806,0.00005370486,0.056529336,0.000047326135,0.0009291986,0.72654545],"study_design_scores_gemma":[0.06640193,0.0063006505,0.22585823,0.0023197886,0.011822317,0.0043016425,0.21607763,0.0033998468,0.18905704,0.0004046689,0.27241707,0.0016392171],"about_ca_topic_score_codex":0.000032605283,"about_ca_topic_score_gemma":0.000009251391,"teacher_disagreement_score":0.7249062,"about_ca_system_score_codex":0.0001699779,"about_ca_system_score_gemma":0.00012680085,"threshold_uncertainty_score":0.575384},"labels":[],"label_agreement":null},{"id":"W2277214561","doi":"10.18553/jmcp.2006.12.5.398","title":"Pharmacy Management Methods in Canada, Including Lower-Cost Therapy for Heartburn","year":2006,"lang":"en","type":"letter","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heartburn; Pharmacy; Intensive care medicine; Physical therapy; Family medicine; Internal medicine; Reflux","score_opus":0.23345561882292634,"score_gpt":0.4970969117919088,"score_spread":0.2636412929689824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277214561","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014340204,0.025919152,0.004023288,0.92141443,0.011533855,0.007850998,0.00022897388,0.000066547145,0.014622541],"genre_scores_gemma":[0.042346746,0.0068183513,0.017004378,0.9235395,0.0068129664,0.00015988572,0.00027189267,0.0002839076,0.002762362],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953157,0.0006159153,0.0015705473,0.00045590763,0.0011809355,0.0008610366],"domain_scores_gemma":[0.99653757,0.0011943424,0.0012301081,0.00035471804,0.00040755168,0.00027568394],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013669025,0.00061753887,0.0013550139,0.00078488,0.00013769403,0.00008004239,0.0005560164,0.00012854428,0.00040676695],"category_scores_gemma":[0.000069624526,0.00051791704,0.00070563465,0.0004144043,0.000040690436,0.00035385482,0.0001344421,0.004022054,0.0000057762836],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00169304,0.00014275257,0.005832062,0.0020492524,0.0010061447,0.007981208,0.00010152355,0.00011596495,0.00015734909,0.00000330597,0.82859015,0.15232724],"study_design_scores_gemma":[0.014884142,0.00015481844,0.00070473045,0.0005194949,0.0012319257,0.00017576158,0.0001664532,0.0005661431,0.0011105357,0.00005102672,0.9799626,0.00047236498],"about_ca_topic_score_codex":0.08128904,"about_ca_topic_score_gemma":0.009325445,"teacher_disagreement_score":0.15185487,"about_ca_system_score_codex":0.0021982659,"about_ca_system_score_gemma":0.0010945956,"threshold_uncertainty_score":0.99972725},"labels":[],"label_agreement":null},{"id":"W2279142588","doi":"10.18553/jmcp.2005.11.5.416","title":"Implementation of the Beers Criteria: Sticks and Stones - or Throw Me a Bone","year":2005,"lang":"en","type":"editorial","venue":"Journal of Managed Care Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"U.S. Air Force","keywords":"Medicine; Alternative medicine; Expert opinion; Evidence-based medicine; Medical education; Pathology","score_opus":0.19711295549435598,"score_gpt":0.4962707813872072,"score_spread":0.2991578258928512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279142588","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04722461,0.03872837,0.00082065345,0.030803297,0.87614465,0.0019401747,0.0032700386,0.000029470179,0.0010387473],"genre_scores_gemma":[0.19054587,0.010806616,0.0017670554,0.0035587915,0.79195297,0.00005475809,0.000113929906,0.00015724637,0.001042732],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99367374,0.0004990523,0.0048588277,0.00032025052,0.00035375167,0.00029436772],"domain_scores_gemma":[0.9894239,0.0013898332,0.008311254,0.00033346884,0.0003968837,0.00014469538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009267386,0.00027993915,0.0014567459,0.00046296942,0.00018096413,0.000115515344,0.00050758163,0.00018563788,0.00065244676],"category_scores_gemma":[0.0020706954,0.0002495223,0.00028540322,0.00016094111,0.00009695497,0.00059816486,0.00012677132,0.0007285242,0.000022107357],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100427904,0.000033355373,0.00090850407,0.001381501,0.00032854537,0.0000065278164,0.0044431854,0.00003976522,0.0000063489833,0.00021039166,0.9908936,0.0016478453],"study_design_scores_gemma":[0.0032140485,0.000119079086,0.0017215478,0.00029801216,0.00020759652,0.00002276082,0.009294634,0.00008648121,0.000022805134,0.00036943035,0.98435634,0.00028723272],"about_ca_topic_score_codex":0.00084398384,"about_ca_topic_score_gemma":0.00047857282,"teacher_disagreement_score":0.14332126,"about_ca_system_score_codex":0.00071838853,"about_ca_system_score_gemma":0.00062343135,"threshold_uncertainty_score":0.9999957},"labels":[],"label_agreement":null},{"id":"W2281510938","doi":"10.18553/jmcp.2007.13.9-a.1","title":"Shrinking Health Care Disparities in Women: The Depression Dilemma","year":2007,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Mental Health Treatment and Access","field":"Psychology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Royal College of Physicians and Surgeons of Canada; Kaiser Permanente","keywords":"Medicine; Dilemma; Depression (economics); Health care; Psychiatry; Gerontology; Economic growth","score_opus":0.032092387318229006,"score_gpt":0.4108677102546799,"score_spread":0.3787753229364509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281510938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966265,0.024546348,0.00005960126,0.002012352,0.0015928277,0.00034607135,0.000004704667,0.000015103617,0.0051579433],"genre_scores_gemma":[0.99533904,0.0003701199,0.00005432677,0.003646005,0.0004322166,0.000016805576,0.000004390345,0.000019214072,0.00011789542],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981327,0.00025429533,0.00061062304,0.00014749197,0.00032339882,0.0005314799],"domain_scores_gemma":[0.9989789,0.00017417266,0.00042913223,0.00017227948,0.000074408286,0.0001711227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010033203,0.00014787703,0.00026243858,0.00023028272,0.00029860716,0.000046876026,0.00036243635,0.00003166448,0.00023608847],"category_scores_gemma":[0.000008668284,0.000096894735,0.000088764966,0.00020729743,0.00003458622,0.00021510653,0.000068699745,0.0005459777,0.000012350637],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013252998,0.00015950117,0.15468416,0.00032363946,0.00007763588,0.0006697272,0.051906224,0.000021979116,0.000017395068,0.0002952102,0.0049388534,0.7855804],"study_design_scores_gemma":[0.010674618,0.0004390259,0.70940745,0.00067352894,0.000059088477,0.00020942777,0.14855678,0.0000054825077,0.000502789,0.00025783578,0.12886627,0.00034772197],"about_ca_topic_score_codex":0.0007694941,"about_ca_topic_score_gemma":0.00020578934,"teacher_disagreement_score":0.78523266,"about_ca_system_score_codex":0.00060914987,"about_ca_system_score_gemma":0.000039482504,"threshold_uncertainty_score":0.39512527},"labels":[],"label_agreement":null},{"id":"W2281697559","doi":"10.18553/jmcp.2013.19.9.740","title":"Comparative Effectiveness of Hypoglycemic Medications Among Veterans","year":2013,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of South Florida; McGill University; Florida Department of Health; U.S. Department of Veterans Affairs","keywords":"Medicine; Internal medicine; Odds ratio; Repaglinide; Rosiglitazone; Metformin; Diabetes mellitus; Type 2 diabetes; Logistic regression; Polypharmacy; Insulin; Endocrinology","score_opus":0.02348004923849426,"score_gpt":0.32931035817338683,"score_spread":0.30583030893489255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281697559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869882,0.001253273,0.00035275897,0.00026254845,0.0002310546,0.00064183224,0.0000027269639,0.000014128683,0.010253487],"genre_scores_gemma":[0.9988911,0.00018932355,0.00052326167,0.00008670577,0.00008461143,0.00002930398,0.000012288969,0.000011681385,0.00017171275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989095,0.00014742058,0.00036267957,0.000099832505,0.0003353762,0.00014519219],"domain_scores_gemma":[0.9987937,0.0001932831,0.00031047006,0.000157374,0.000405435,0.00013973375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002641386,0.00012520564,0.00046288143,0.000248235,0.00003843799,0.000014748799,0.0001415355,0.000019013482,0.0002167271],"category_scores_gemma":[0.000019540088,0.000094244955,0.00019195178,0.0001794704,0.000084439765,0.00025950003,0.000033841618,0.0001895551,0.000029868836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038034618,0.0037637288,0.488424,0.0078104367,0.01947954,0.0007340834,0.019743066,0.0006933837,0.14093259,0.0009994732,0.034533337,0.2790829],"study_design_scores_gemma":[0.022460338,0.0015506305,0.87878764,0.0017643138,0.0047821635,0.000056261568,0.00627595,0.0005405314,0.07384253,0.00033236798,0.009280558,0.00032673415],"about_ca_topic_score_codex":0.00006850792,"about_ca_topic_score_gemma":0.0000022242389,"teacher_disagreement_score":0.39036363,"about_ca_system_score_codex":0.00010723708,"about_ca_system_score_gemma":0.00004751734,"threshold_uncertainty_score":0.38431978},"labels":[],"label_agreement":null},{"id":"W2282033865","doi":"10.18553/jmcp.2002.8.5.365","title":"Preventable Drug-related Morbidity in Older Adults-1. Indicator Development (Part 1 of a 2-part series)","year":2002,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Delphi method; Pharmaceutical care; Health care; Causality (physics); Family medicine; Pharmacy","score_opus":0.07604677687570777,"score_gpt":0.3559927667166806,"score_spread":0.27994598984097285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282033865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869927,0.004803253,0.0000062854256,0.0016946201,0.0006876121,0.0005338438,0.0000071283957,0.000016201137,0.0052583455],"genre_scores_gemma":[0.9956852,0.0017808144,0.00045222658,0.0005262764,0.00012985809,0.000008750262,0.000008378319,0.000022951128,0.0013855221],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976059,0.00018924192,0.0010982812,0.00017621355,0.00063216966,0.0002981582],"domain_scores_gemma":[0.99849945,0.00011890967,0.0007585234,0.00016460681,0.00017851415,0.0002799833],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062498415,0.00018983164,0.00052205793,0.00030191845,0.00005610916,0.000013586306,0.00019978799,0.000046994708,0.0030679002],"category_scores_gemma":[0.00011343491,0.00015677951,0.00017851056,0.0003422645,0.000049728853,0.0005065435,0.000074612195,0.00077246473,0.000050498762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054556364,0.0052960366,0.73914677,0.004580897,0.0018701925,0.002207494,0.029721776,0.00015331277,0.0011293603,0.000049613765,0.077378154,0.13301076],"study_design_scores_gemma":[0.02826929,0.00036481643,0.06782601,0.002312476,0.00094262837,0.00048959156,0.004174107,0.0005919989,0.030093795,0.000018477527,0.8644166,0.0005001844],"about_ca_topic_score_codex":0.00002459741,"about_ca_topic_score_gemma":0.000010985795,"teacher_disagreement_score":0.78703845,"about_ca_system_score_codex":0.00019056954,"about_ca_system_score_gemma":0.00010668277,"threshold_uncertainty_score":0.99784344},"labels":[],"label_agreement":null},{"id":"W2287063926","doi":"10.18553/jmcp.2006.12.7.578","title":"PPIs Are Therapeutically Interchangeable and Ideal for a Managed Care Intervention Such as Therapeutic MAC","year":2006,"lang":"en","type":"letter","venue":"Journal of Managed Care Pharmacy","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rabeprazole; Intervention (counseling); Pharmacy; Managed care; Esomeprazole; Drug; Intensive care medicine; Activity-based costing; Therapeutic effect; Medical emergency; Emergency medicine; Pharmacology; Family medicine; Internal medicine; Proton-pump inhibitor; Nursing; Health care","score_opus":0.07558420101270502,"score_gpt":0.39766980958942366,"score_spread":0.32208560857671864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287063926","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011017896,0.21736154,0.0017424616,0.7544075,0.002671907,0.0030562945,0.0002157537,0.00011391059,0.009412693],"genre_scores_gemma":[0.48279592,0.013255259,0.00065842347,0.49061424,0.008169816,0.00013676008,0.0002905874,0.00026579134,0.0038132197],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965108,0.00044640794,0.0010400512,0.0004926928,0.00082722993,0.0006828297],"domain_scores_gemma":[0.9966411,0.00066980865,0.0012047725,0.0002896379,0.0009802011,0.00021447771],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00070872915,0.00060796,0.0012187777,0.0004374737,0.00028313624,0.00021750407,0.00041884102,0.000322642,0.00032680287],"category_scores_gemma":[0.000089471156,0.00047713754,0.00095193944,0.0002124212,0.00014483447,0.00032293797,0.00019116755,0.003366292,0.000020214482],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004278621,0.00023977914,0.0014135898,0.013609432,0.0054342505,0.0045027114,0.0022935176,0.0000038081996,0.00036056238,0.000034402463,0.6588399,0.3089894],"study_design_scores_gemma":[0.007504012,0.00095558964,0.0007721664,0.0012667454,0.0057166535,0.0004925589,0.0038635253,0.0000623243,0.00041208774,0.00039227412,0.9781088,0.00045324734],"about_ca_topic_score_codex":0.00018367625,"about_ca_topic_score_gemma":0.00005337315,"teacher_disagreement_score":0.471778,"about_ca_system_score_codex":0.00042826336,"about_ca_system_score_gemma":0.00008666165,"threshold_uncertainty_score":0.999768},"labels":[],"label_agreement":null},{"id":"W2288948277","doi":"10.18553/jmcp.2008.14.s1-a.1a","title":"The Challenge of Compliance and Persistence: Focus on Ulcerative Colitis","year":2008,"lang":"en","type":"review","venue":"Journal of Managed Care Pharmacy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; McGill University; National Cancer Institute; Crohn's and Colitis Foundation of America","keywords":"Medicine; Psychosocial; Population; Ulcerative colitis; Intensive care medicine; Disease; Adverse effect; Regimen; Health care; Persistence (discontinuity); Patient education; Medication adherence; Family medicine; Internal medicine; Environmental health; Psychiatry","score_opus":0.12122900713347373,"score_gpt":0.3867234102996507,"score_spread":0.26549440316617695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288948277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011516655,0.9881683,0.000002948827,0.0007548807,0.00017577191,0.0005435685,0.00003603253,0.000004597387,0.0103023965],"genre_scores_gemma":[0.012030159,0.98748213,0.000036924055,0.000028692879,0.00018216709,0.00001268006,0.0000057399343,0.000025953432,0.00019556221],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851215,0.00021796522,0.0005527266,0.00016026673,0.0003875765,0.00016932658],"domain_scores_gemma":[0.9984642,0.00024432794,0.0006821283,0.00020503519,0.0002733685,0.00013093492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014895752,0.00026526517,0.0012091219,0.00012540368,0.00017128386,0.000015630292,0.00017201366,0.000055889992,0.000021537366],"category_scores_gemma":[0.000029377492,0.00014746937,0.0005960678,0.00011627199,0.00013825083,0.000044396238,0.000038507704,0.0006789655,0.0000052952623],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017164025,0.000109770204,0.000022361144,0.0063576396,0.0010976909,0.00021653702,0.0007578495,1.1070782e-7,4.1623572e-8,0.000109300076,0.0004695745,0.9906875],"study_design_scores_gemma":[0.0020369408,0.00065920665,0.00026807847,0.012319947,0.0021839773,0.0011846541,0.00060380914,0.0000011357017,0.0000035789083,0.000043945478,0.9805727,0.00012201216],"about_ca_topic_score_codex":0.00001288311,"about_ca_topic_score_gemma":0.00002260941,"teacher_disagreement_score":0.9905655,"about_ca_system_score_codex":0.00017172833,"about_ca_system_score_gemma":0.00021279916,"threshold_uncertainty_score":0.60136265},"labels":[],"label_agreement":null},{"id":"W2292245429","doi":"10.18553/jmcp.2011.17.s9-a.s27","title":"Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness Research","year":2011,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"H2020 European Research Council; U.S. Food and Drug Administration; National Institutes of Health; Pfizer","keywords":"Medicine; Psychological intervention; Comparative effectiveness research; Quality of life (healthcare); Health care; Nausea; Set (abstract data type); Physical therapy; Intensive care medicine; Alternative medicine; Psychiatry; Surgery; Nursing","score_opus":0.8433772274253245,"score_gpt":0.5505320714857466,"score_spread":0.29284515593957794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292245429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918718,0.00049739156,0.00012067887,0.004004574,0.00041090907,0.0007711381,0.000042183943,0.0000053303606,0.0022760273],"genre_scores_gemma":[0.9978981,0.00005381407,0.00053191243,0.0014011118,0.00004133286,0.000034754357,0.0000017075688,0.000012618568,0.000024647661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99396414,0.0022922433,0.0031252147,0.00019467826,0.00019716843,0.00022655158],"domain_scores_gemma":[0.9892346,0.007373334,0.002509939,0.00031202417,0.00048198533,0.00008808555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014043159,0.00012192538,0.00083939603,0.000727743,0.00015880573,0.000046973197,0.00020221571,0.000037991496,0.000290592],"category_scores_gemma":[0.005044445,0.00010481997,0.000153058,0.00026213285,0.000116540956,0.00050107244,0.0000464912,0.0005155447,0.00007329954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048736273,0.00085940806,0.78147393,0.00042658893,0.00081969827,0.000081450875,0.06564625,0.002512943,0.000041565265,0.12882702,0.018480431,0.0003433703],"study_design_scores_gemma":[0.0067335917,0.00089618063,0.8930494,0.0007335195,0.000062597646,0.00004759802,0.032138385,0.0012936274,0.0023915647,0.038591366,0.02349546,0.0005666611],"about_ca_topic_score_codex":0.0010273525,"about_ca_topic_score_gemma":0.00013657987,"teacher_disagreement_score":0.11157554,"about_ca_system_score_codex":0.00038939386,"about_ca_system_score_gemma":0.00016333644,"threshold_uncertainty_score":0.60390365},"labels":[],"label_agreement":null},{"id":"W2296952336","doi":"10.18553/jmcp.2002.8.5.406","title":"Clinical Pharmacist Interventions Associated with Appropriateness and Lengthof Inpatient Antimicrobial Therapy for Pneumonia","year":2002,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pneumonia; Psychological intervention; Pharmaceutical care; Clinical pharmacy; Pharmacist; Antimicrobial stewardship; Emergency medicine; Antibiotics; Intensive care medicine; Pharmacy; Internal medicine; Antibiotic resistance; Family medicine; Nursing","score_opus":0.12287502161693276,"score_gpt":0.3959279199479969,"score_spread":0.27305289833106416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296952336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950423,0.0010101086,0.00058025157,0.001762521,0.0007022137,0.0005894254,0.000025557985,0.00003209395,0.00025549394],"genre_scores_gemma":[0.9957505,0.0025322314,0.00014596138,0.0010221867,0.00034273247,0.000016167594,0.000008246463,0.000031106214,0.00015088328],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850684,0.00018942142,0.0007035167,0.00017592893,0.0002186098,0.00020570886],"domain_scores_gemma":[0.9984596,0.00014447948,0.000530908,0.00011488509,0.0005514827,0.00019863973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000499677,0.00017043493,0.00045880093,0.00021313224,0.00019910606,0.00004317851,0.0001042584,0.00005437388,0.00005069503],"category_scores_gemma":[0.000101245794,0.00011952758,0.00043676532,0.00018415245,0.00011122447,0.00017211863,0.000025288657,0.0004973764,0.0000030922918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035473856,0.0070360093,0.4946971,0.0013963913,0.005374017,0.0008293783,0.0028977178,0.00012284196,0.070897676,0.000026209176,0.013203269,0.39997202],"study_design_scores_gemma":[0.18448001,0.017056612,0.3218928,0.0048503797,0.008087188,0.0038890254,0.0021699925,0.0036350584,0.01845489,0.000057095534,0.4336799,0.0017470457],"about_ca_topic_score_codex":0.0000020839877,"about_ca_topic_score_gemma":0.000003710696,"teacher_disagreement_score":0.42047665,"about_ca_system_score_codex":0.00007729815,"about_ca_system_score_gemma":0.00005150786,"threshold_uncertainty_score":0.48741934},"labels":[],"label_agreement":null},{"id":"W2299322097","doi":"10.18553/jmcp.2005.11.s1-b.1","title":"Trends in the Management of Type 2 Diabetes: An Emerging Role for Insulin","year":2005,"lang":"en","type":"review","venue":"Journal of Managed Care Pharmacy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, New York University; National Institutes of Health; York University; University of Pennsylvania; GlaxoSmithKline; Washington State University; AstraZeneca; Bristol-Myers Squibb; Pfizer; Novo Nordisk; American Diabetes Association","keywords":"Medicine; Glycemic; Insulin; Type 2 diabetes; Diabetes mellitus; Intensive care medicine; Basal insulin; Pharmacy; Diabetes management; Internal medicine; Endocrinology; Family medicine","score_opus":0.07207173885985754,"score_gpt":0.4106241114465462,"score_spread":0.3385523725866887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299322097","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046129126,0.99231964,0.0000064723604,0.00020388298,0.00034772753,0.0010951759,0.000015240618,0.00001247063,0.005538093],"genre_scores_gemma":[0.0027463946,0.99465454,0.0010243469,0.0001921623,0.0005054839,0.00007818663,0.00016580729,0.000062890205,0.00057017815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976262,0.0001772997,0.0010969717,0.00024370258,0.00050222746,0.0003535922],"domain_scores_gemma":[0.998338,0.00008250527,0.0009017093,0.00040857427,0.00016464369,0.000104575665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009024103,0.0003864748,0.0015255131,0.0011149319,0.000047119902,0.000035955585,0.00056897156,0.00006332986,0.00009836285],"category_scores_gemma":[0.000008538933,0.00024379104,0.00085469685,0.0007847903,0.000027033151,0.00018525864,0.00008377844,0.0004194515,0.000005789429],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007896081,0.00039479815,0.000026188103,0.015211418,0.0019677365,0.00012493227,0.00047583343,0.000013991385,3.914045e-7,0.00008298433,0.0017892371,0.97983354],"study_design_scores_gemma":[0.003010533,0.0005157333,0.00006596615,0.0073568886,0.01121702,0.000009315983,0.0012958254,0.00003220051,0.000002972652,0.000017330878,0.9762864,0.00018977966],"about_ca_topic_score_codex":0.0000031455234,"about_ca_topic_score_gemma":0.0000033348608,"teacher_disagreement_score":0.97964376,"about_ca_system_score_codex":0.00024096966,"about_ca_system_score_gemma":0.00005635935,"threshold_uncertainty_score":0.99415106},"labels":[],"label_agreement":null},{"id":"W9251540","doi":"10.18553/jmcp.2014.20.4.376","title":"Simultaneous Use of Amiodarone Influences Warfarin Maintenance Dose but Is Not Associated with Adverse Events","year":2014,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Saint-Boniface","funders":"Ministério da Saúde; Universidade de São Paulo","keywords":"Amiodarone; Medicine; Warfarin; Adverse effect; Odds ratio; CYP2C9; Maintenance dose; VKORC1; Internal medicine; Atrial fibrillation; Prothrombin time; Loading dose; Anesthesia; Gastroenterology","score_opus":0.08974925117754175,"score_gpt":0.3912391506886126,"score_spread":0.30148989951107086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W9251540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956974,0.0008748791,0.00029724446,0.00058911234,0.0012809896,0.0003676921,0.00019124696,0.000035691985,0.0006657791],"genre_scores_gemma":[0.9919587,0.0016245111,0.0005663724,0.0047344887,0.00030186155,0.00000806381,0.0000111959525,0.000052580574,0.00074225845],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616694,0.0010427235,0.0010925407,0.00033593865,0.00072726386,0.0006346081],"domain_scores_gemma":[0.99530685,0.0012272457,0.0015683321,0.00027366335,0.0011570608,0.0004668266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001328952,0.00042688518,0.00080303464,0.00033157654,0.00021946816,0.000020745218,0.00073434913,0.0001680262,0.00031561166],"category_scores_gemma":[0.00062152854,0.0003438763,0.00032469333,0.0004163016,0.00027059033,0.00043020383,0.00015695777,0.0013225678,0.000023242545],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018508457,0.002868815,0.13913369,0.00078841473,0.0074203564,0.0023782582,0.010533786,0.19930674,0.3428561,0.00034226253,0.009677581,0.26618552],"study_design_scores_gemma":[0.037700783,0.0011133208,0.034070704,0.00048955233,0.004865496,0.0002941529,0.0013077764,0.030303068,0.339064,0.0003612016,0.54887867,0.001551255],"about_ca_topic_score_codex":0.000072516355,"about_ca_topic_score_gemma":0.000018957333,"teacher_disagreement_score":0.5392011,"about_ca_system_score_codex":0.00013194527,"about_ca_system_score_gemma":0.00018320778,"threshold_uncertainty_score":0.99990135},"labels":[],"label_agreement":null}]}